Potent and Stable Attenuation of Live-HIV-1 by Gain of a Proteolysis-resistant Inhibitor of NF-κB (IκB-αS32/36A) and the Implications for Vaccine Development
Open Access
- 1 June 1999
- journal article
- Published by Elsevier
- Vol. 274 (25) , 17567-17572
- https://doi.org/10.1074/jbc.274.25.17567
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Chemokine Receptors: Keys to AIDS Pathogenesis?Cell, 1998
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Simian immunodeficiency viruses containing mutations in the long terminal repeat NF-κB or Sp1 binding sites replicate efficiently in T cells and PHA-stimulated PBMCsVirus Research, 1997
- Host factors and the pathogenesis of HIV-induced diseaseNature, 1996
- An Essential Role for NF-κB in Preventing TNF-α-Induced Cell DeathScience, 1996
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.The Journal of Experimental Medicine, 1995
- Correction of Radiation Sensitivity in Ataxia Telangiectasia Cells by a Truncated IκB-αScience, 1995
- Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cellsThe Lancet, 1995
- Protective Effects of a Live Attenuated SIV Vaccine with a Deletion in the nef GeneScience, 1992